OR WAIT null SECS
Joint venture aims to streamline handling of tissue and samples and subsequent digitization in support of clinical trial endpoint generation.
Clario, a healthcare research technology company, and CellCarta, an organization focused on integrated sample management and specialized laboratory services, have announced a strategic partnership aimed to improve clinical trial sample handling. Additionally, the companies hope to streamline the handling of tissue and samples and subsequent digitization in support of clinical trial endpoint generation across multiple therapeutic areas, including oncology, hepatology (e.g., NASH), and gastroenterology (e.g., UC and Crohn's).
"This collaboration brings together Clario's cutting-edge scientific expertise and unrivaled clinical trial endpoint solutions with CellCarta's unparalleled sample processing and management expertise," noted Joyce Suhy, PhD, EVP, medical imaging, and specialty solutions, Clario. "This partnership advances Clario's ability to support histopathology studies, providing our customers with full visibility for biopsy sample logistics and significantly accelerates delivery of centralized assessments for eligibility and efficacy endpoints."
Reference: Clario teams up with CellCarta to transform clinical trial sample management for histopathology studies. PR Newswire. September 26, 2023. Accessed September 27, 2023. https://www.prnewswire.com/news-releases/clario-teams-up-with-cellcarta-to-transform-clinical-trial-sample-management-for-histopathology-studies-301937860.html